Seeking Alpha

Vertex Pharmaceuticals Inc. (VRTX)

()

News & PR
Market Currents

Buzz
Twitter: VRTX

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Innovative Drug Companies Headline the Gainers

Nov 2 • Ockham Research • 1 Comment
Monday Options Update: XLF, ETFC, CF, HGSI, EEM, BEBE, SMH and VRTX

Nov 2 • Andrew Wilkinson • Comment!
Monday Options Recap

Nov 2 • Frederic Ruffy • 6 Comments
Wall Street Breakfast: Must-Know News

Oct 27 • SA Editor Eli Hoffmann • 13 Comments
Capital Markets Open Up to Biotechs

Oct 4 • The Burrill Report • Comment!
Vertex Set to See More Volatility on Hepatitis Drug Data Release

Aug 25 • optionMONSTER • Comment!
Wall Street Breakfast: Must-Know News

Aug 6 • SA Editor Rachael Granby • 13 Comments
15 Necessary Components for the Next Leg Higher

Jul 21 • The Inflection Point • 5 Comments
Is IBB the Best Biotech ETF?

Jul 2 • Don Dion • 1 Comment
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch

Jun 28 • Marco Hickey • 1 Comment
Thursday Options Update: FXI, IYR, YGE, VRTX & XLF

Jun 4 • Andrew Wilkinson • Comment!
Vertex: Long Term Buy Opportunity

Jun 2 • Zacks.com • Comment!
Where the Big Money Is Betting Big

May 15 • Andrew Mickey • 45 Comments
Thursday Options Update: XRT, CLF, WFMI & VRTX

May 14 • Andrew Wilkinson • 1 Comment
Sequenom's Bombshell

Apr 30 • TraderMark • 13 Comments
A Look at D.E. Shaw's Q408 Holdings: Just for Fun

Apr 22 • Market Folly • 2 Comments
Tudor Investment Takes New Positions in Financials, Among Others

Mar 17 • Market Folly • 3 Comments
Biopharma: Instead of M&A, Think P&A

Mar 4 • Mike Huckman • 2 Comments
Vertex to Buy Hepatitis C Drug Developer ViroChem for $375 Million

Mar 4 • Eben Tessari • Comment!
80 Winning Stocks That Have Nothing to Do with Gold

Feb 27 • TraderMark • 14 Comments
IBB: Newfound Stability Lures Biotech Investors

Feb 18 • Don Dion • Comment!
Hedge Fund Portfolio Tracking: D.E. Shaw & Co (David E. Shaw), Q3 2008

Jan 16 • Market Folly • 1 Comment
How Is the Biotech Industry Holding Up?

Jan 14 • Mike Huckman • Comment!
9 Possible Pharma Deals for 2009

Jan 8 • Zacks.com • 7 Comments
2009: Positive Outlook for Biotech

Jan 8 • Michael Becker • 1 Comment
2008 Stock Market: 51 Rays of Light

Jan 7 • Market Folly • 1 Comment
Fast Money Recap - Bullish on Biotech (1/5/09)

Jan 6 • SA Editor Miriam Metzinger • Comment!
Hedge Fund Tracking: Farallon Capital Management (Thomas Steyer), Q3 2008

Jan 6 • Market Folly • 2 Comments
Pharma Stocks Buck the Market Trend

Dec 29, 2008 • Mike Huckman • Comment!
Vertex's $75K Question

Dec 19, 2008 • Mike Huckman • Comment!
Nasdaq 100 Struggles

Sep 3, 2008 • Bespoke Investment Group • Comment!
5 Potential Buyout Targets in Biotech - Barron's

Aug 17, 2008 • SA Editor Rachael Granby • 9 Comments
Earnings Preview: Vertex Pharmaceuticals

Jul 30, 2008 • theflyonthewall.com • Comment!
Big Biotech Booms But IBB Falls Flat

Jul 16, 2008 • Don Dion • 1 Comment
Biotech Fundamentals Still Look Strong

Jun 13, 2008 • A. Reza Saadat • Comment!
Russell 1,000 Stocks Up and Down the Most Since the 3/10 Bottom

May 5, 2008 • Bespoke Investment Group • 2 Comments
FDA's "Risky Business" for Pharma & Biotech

Apr 29, 2008 • Mike Huckman • Comment!
Schering Beat the Street and Plows Through Vytorin Firestorm

Apr 23, 2008 • Mike Huckman • Comment!
Stocks with Biggest Gains Last Week; Furthest Above 50-DMAs

Apr 7, 2008 • Bespoke Investment Group • 1 Comment
Best and Worst Performers Since the 3/10 Bottom

Apr 3, 2008 • Bespoke Investment Group • Comment!
Vertex's Telaprevir May Become a Multi-Billion Dollar Drug

Apr 2, 2008 • A. Reza Saadat • 3 Comments

Vertex Pharmaceuticals Inc. (VRTX)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers